SEC Form 4 · accession 0001567619-18-005879
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1,F2 | Nov 9, 2018 | F | 3,417 | $106.94 | D | 253,074 | D | |
| ResMed Common StockF3 | Nov 9, 2018 | F | 8,092 | $106.94 | D | 244,982 | D | |
| ResMed Common StockF4 | Nov 9, 2018 | F | 4,495 | $106.94 | D | 240,487 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.
- F2Includes 199.72 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan
- F3Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
- F4Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.